- Market Capitalization, $K 272,313
- Shares Outstanding, K 186,516
- Annual Sales, $ 1,070 K
- Annual Income, $ -27,020 K
- 60-Month Beta 2.96
- Price/Sales 265.95
- Price/Cash Flow N/A
- Price/Book 1.67
|Period||Period Low||Period High||Performance|
| || |
-0.09 (-5.81%)since 05/24/19
| || |
-0.22 (-13.10%)since 03/26/19
| || |
-2.11 (-59.10%)since 06/26/18
Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior leadership to further strengthen the...
Geron (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies for patients with MDS and myelofibrosis. The candidate is progressing well in clinical studies.
Geron Corporation (Nasdaq: GERN) today announced that two abstracts containing clinical data and analyses related to imetelstat, the Company's first-in-class telomerase inhibitor, have been accepted for...
Geron Corporation (Nasdaq: GERN) today provided an update to its 2019 corporate objectives for the imetelstat program.
Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition of a Vice President, Biometrics, and a Vice President, Manufacturing....
Geron (GERN) posts narrower-than-expected loss in first-quarter 2019 but misses on revenues. Operating expenses increase on a year-over-year basis.
MENLO PARK, Calif. (AP) _ Geron Corp. (GERN) on Thursday reported a loss of $10.1 million in its first quarter.
Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company had approximately $170 million in cash and marketable securities,...
Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team's senior leadership with the addition of three highly experienced professionals for key functional areas. Their oncology...
Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...